All articles tagged: Overweight (E66.3)
HealthDay
25 June at 03.01 PM
Intermittent Fasting Aids Early Diabetes Outcomes More Than DrugsIntermittent fasting may be a more effective intervention than drugs for people with early diabetes and either obesity or overweight, according to a study published online June 21 in JAMA Network Open.Lixin Guo, M.D., from the Chinese Academy of Medical Sciences in Beijing, and colleagues evaluated the effect of intermittent fasti |
HealthDay
20 June at 08.50 PM
Timing of Exercise Significant for Obesity, Metabolic ImpairmentFor sedentary adults with obesity/overweight and metabolic impairments, the timing of moderate-to-vigorous physical activity (MVPA) is significant, with a beneficial effect on glucose homeostasis for accumulation of more MVPA in the evening, according to a study published online June 10 in Obesity.Antonio Clavero-Jimeno, from the Univ |
Evalytics
05 March at 06.03 AM
Metformin's Potential Beyond Diabetes: Exploring Diverse Health BenefitsMetformin, a frontline treatment for type 2 diabetes, has long been a pharmaceutical mainstay, with over 91 million prescriptions in 2021 alone. However, recent evidence suggests that metformin's efficacy extends beyond diabetes management, encompassing various conditions such as cancer, obesity, liver disease, cardiovascular issues, neurodegenerative disorders, and renal diseases. As research exp |
HealthDay
31 January at 04.57 PM
Cardio, Cardio + Resistance Training Improve CVD Risk Profile at One YearIn adults with overweight or obesity, aerobic exercise alone or a combined resistance plus aerobic exercise program leads to improvements in composite cardiovascular disease (CVD) risk profiles at one year, according to a study published online Jan. 17 in the European Heart Journal.Duck-chul Lee, Ph.D., from Iowa State Universit |
HealthDay
30 January at 04.20 PM
Diabetes Risk in Overweight, Obese Teens Varies Substantially by Baseline HbA1cFive-year diabetes risk among teens with overweight or obesity varies substantially by baseline HbA1c levels, according to a study published online Jan. 17 in JAMA Network Open.Francis M. Hoe, M.D., from Kaiser Permanente Roseville Medical Center in California, and colleagues assessed the risk for future type 2 diabetes (T2D) amon |
HealthDay
17 January at 04.52 PM
Individual Variation in Depressive Symptoms Tied to Subsequent Weight GainWEDNESDAY, Jan. 17, 2024 (HealthDay News) -- Individuals with overweight or obesity are more vulnerable to short-term weight gain following individual increases in depressive symptoms, according to a study published online Jan. 10 in PLOS ONE.Julia Mueller, Ph.D., from the University of Cambridge in the United Kingdom, and colleagues assessed how small fluctuations in |
HealthDay
12 January at 04.32 PM
Rate of Twin Births Increased in Pregnancies With Higher BMIThe rate of twin deliveries increased with increasing body mass index (BMI), and part of this association was explained by higher use of assisted reproductive technology (ART), according to a study published online Jan. 9 in JAMA Network Open.Jeffrey N. Bone, from the University of British Columbia in Vancouver, Canada, and colleag |
HealthDay
09 January at 05.09 PM
Risk for Suicidal Ideation Not Increased With SemaglutideFor individuals with overweight or obesity and type 2 diabetes, semaglutide is not associated with an increased risk for suicidal ideation compared with non-glucagon-like peptide 1 receptor (GLP1R) agonist antiobesity medications, according to a study published online Jan. 5 in Nature Medicine.William Wang, from the Case Western Reserve |
HealthDay
13 December at 10.08 PM
New Poll Finds Older Americans Believe Medicare Should Cover Weight-Loss DrugsAccording to the latest University of Michigan National Poll on Healthy Aging, about three in four older Americans (76 percent) believe Medicare should cover the cost of weight-loss medications like Ozempic, Wegovy, or Zepbound.More than four out of five older adults (83 percent) think insurance companies should pay for drugs that help people |
HealthDay
13 December at 03.42 PM
Perfluorooctanesulfonic Acid Exposure Linked to Lower Bone DensityIn a cohort of Hispanic adolescents and young adults, plasma perfluorooctanesulfonic acid (PFOS) exposure is associated with lower bone mineral density (BMD), according to a study published online Dec. 6 in Environmental Research.Emily Beglarian, M.P.H., from the Keck School of Medicine at the University of Southern California in Los |
HealthDay
13 December at 03.33 PM
Increasing Body Mass Index Tied to 18 Site-Specific Cancers in MenIncreasing body mass index (BMI) at age 18 years is associated with development of subsequent site-specific cancers in men, according to a study published online Nov. 6 in Obesity.Aron Onerup, M.D., Ph.D., from the University of Gothenburg in Sweden, and colleagues examined BMI at age 18 years and incident site-specific cancer ( |
HealthDay
12 December at 04.02 PM
Small Proportion of Advanced Breast Cancers Due to Biennial Versus Annual MammogramAmong routinely screened women, only a small proportion of advanced breast cancers is attributed to biennial versus annual screening, according to a study published online Dec. 7 in JAMA Oncology.Karla Kerlikowske, M.D., from the University of California in San Francisco, and colleagues examined the population attributable risk proport |
HealthDay
11 December at 11.55 PM
High BMI in Adolescence Linked to Early CKD in Young AdulthoodHigh body mass index (BMI) in late adolescence is associated with early chronic kidney disease (CKD) in young adulthood, according to a study published online Dec. 11 in JAMA Pediatrics.Avishai M. Tsur, M.D., from the Israel Defense Forces, Medical Corps, in Ramat Gan, and colleagues examined the association between adolescent BMI and e |
HealthDay
11 December at 04.32 PM
Risk for CRC Reduced With GLP-1RAs for Drug-Naive Patients With T2DFor drug-naive patients with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonists (GLP-1RAs) are associated with a reduced risk for colorectal cancer (CRC) compared with other antidiabetics, including insulin and metformin, according to a research letter published online Dec. 7 in JAMA Oncology.Lindsey Wang, from the Case We |
HealthDay
07 December at 04.41 PM
Slow-to-Moderate Weight Loss Linked to Lower Mortality in Knee, Hip OAFor individuals with overweight or obesity and knee or hip osteoarthritis (OA), a slow-to-moderate, but not a fast, rate of weight loss is associated with a reduced risk for all-cause mortality, according to a study published online Dec. 6 in Arthritis & Rheumatology.Jie Wei, Ph.D., from Xiangya Hospital in Changsha, China, and col |
HealthDay
05 December at 04.19 PM
Lower Pregnancy Weight Gain Seen for Women Who Undergo Bariatric SurgeryWomen who have undergone bariatric surgery have lower pregnancy weight gain, according to a study published online Dec. 5 in JAMA Network Open.Huiling Xu, M.D., from the Karolinska Institutet in Stockholm, and colleagues compared pregnancy weight gain among women with a history of bariatric surgery versus those without in a nationwide, |
HealthDay
28 November at 04.42 PM
Impacts of Gestational Weight Gain Seen 50+ Years LaterGestational weight gain might have implications that extend beyond the pregnancy window to long-term health, according to a study published in the Nov. 18 issue of The Lancet.Stefanie N. Hinkle, Ph.D., from the Perelman School of Medicine at the University of Pennsylvania in Philadelphia, and colleagues assessed whether gestationa |
HealthDay
09 November at 04.08 PM
FDA Approves New Diet Drug Zepbound, a Version of the Diabetes Med MounjaroA second injectable diabetes drug has been approved for weight loss in overweight and obese adults, the U.S. Food and Drug Administration announced Wednesday. The weight-loss drug Zepbound contains the same active ingredient, tirzepatide, as the diabetes drug Mounjaro.Zepbound works by activating hormone receptors in the body to reduce appetite |
Medical xPress
30 June at 07.40 AM
Decision to offer sedation for often-painful IUD insertion is 'groundbreaking,' health experts sayIntrauterine devices (IUDs) are a highly effective and long-lasting form of birth control placed in the uterus. Research shows that many people who get IUDs experience moderate to intense pain during the insertion. But it wasn't until recently that providers began to acknowledge this and do something about it. |
HealthDay
27 June at 03.19 PM
Immunoglobulin Replacement Therapy Beneficial for Blood CancersImmunoglobulin replacement therapy (IgRT) is associated with reductions in hypogammaglobulinemia, infections, severe infections, and associated antimicrobial use among real-world patients with chronic lymphocytic leukemia (CLL) or non-Hodgkin lymphoma (NHL), according to a study published online June 21 in Blood Advances.Jacob D. Soum |
Medpage Today
26 June at 04.59 PM
When Was the Last Time You Really Talked With Your Patient?My 10 o'clock patient's name is Maria*. Her chart has three "health maintenance" flags that are bright red, indicating that she is more than 3 years overdue for a mammogram, more than 6 years overdue for a Pap smear, and has... |
Medpage Today
23 June at 09.21 PM
Novel Triple-Hormone Agonist Boosts Beta-Cell Function in T2DORLANDO -- An investigational triple-hormone receptor agonist improved metabolic profiles of people with obesity with or without type 2 diabetes, an exploratory biomarker analysis of a phase II trial found. After 36 weeks... |
Medpage Today
22 June at 06.00 PM
Fenofibrate Slows Diabetic Retinopathy ProgressionORLANDO -- The cholesterol drug fenofibrate reduced progression of early eye disease among diabetes patients, the LENS trial showed. The fibrate reduced progression of early diabetic retinopathy or maculopathy by a relative... |
Medpage Today
22 June at 06.00 PM
Preventing Surgical-Site Infections; Drugs Go Head to Head for Ischemic StrokeTTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center... |
Medical xPress
22 June at 05.20 PM
Lawsuit could challenge trust in Ozempic and other popular weight loss drugsThe manufacturers of the most popular weight loss drugs are being challenged in court. |
HealthDay
21 June at 03.38 PM
Overall Prevalence of Being Up-to-Date With Lung Cancer Screening Is LowThe overall prevalence of up-to-date (UTD) lung cancer screening (LCS) was low in 2022, with prevalence increasing with age and number of comorbidities, according to a study published online June 10 in JAMA Internal Medicine.Priti Bandi, Ph.D., from the American Cancer Society in Atlanta, and colleagues estimated the contemporary preval |
Medpage Today
13 June at 06.56 PM
Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break?Finding a way to dissociate the activity of effector T cells from regulatory T cells could make immune checkpoint inhibitors more effective in the 60% of melanoma patients who do not benefit or develop resistance to the drugs... |
Medpage Today
08 June at 04.00 PM
Here Are the Top Supreme Court Health Cases to WatchBy early July, the Supreme Court will release its most controversial rulings for the 2023-2024 term. The Court's 6-3 conservative supermajority has already overturned Roe v. Wade, sharply limited affirmative action, expanded... |